Wall Street Unplugged
Episode: 585January 11, 2018

It’s Conference Season!

Marc Lichtenfeld

Welcome back to another episode of Wall Street Unplugged.

As you may know, I’ve been reporting live from the 2018 Consumer Electronics Show this week. And I’ve got some interesting observations to report…  

But on this week’s show, we’re going to focus on another major conference investors shouldn’t overlook: the annual J.P. Morgan Healthcare Conference. It’s attended by 400-plus biotech companies and over 10,000 industry professionals.

And today I’ve reached out to my No. 1 healthcare industry analyst, Marc Lichtenfeld, to give us the inside scoop.

Marc is Chief Income Strategist at The Oxford Club. He’s covered the biotech and healthcare sectors for over a decade.

Tune in as Marc talks about promising new drug development and innovation across the healthcare sector… and why he thinks biotech has finally reached an “inflection point.”

Marc also reveals two small-cap biotech companies with untapped potential.

Good Investing,

Frank Curzio

Download Transcript
What’s really moving these markets?
Get free daily updates
More Wall Street Unplugged
Uranium

This uranium leader could be Trump’s next investment

Will Trump take a stake in this uranium stock next? Plus, this commodities bull market is unlike any other… Trump's USA Rare Earth (USAR) stake… The Fed meeting could surprise the market… Starbucks' (SBUX) turnaround… And Boeing's (BA) upside.

Netflix

Netflix is dead

Netflix (NFLX) is a dead stock—here's what killed it. Plus, small caps are starting 2026 off strong… Trump's Powell investigation is a bad move… Big bank earnings… Bitcoin's (BTC) rebound… And crypto vs. crypto treasuries: Which is the better investment?

2026

Frank’s No. 1 stock pick for 2026

This stock has been a black eye for years—but it’s about to make a comeback. Plus, Trump, Venezuela, and Greenland… The best market ever for big banks… Don't trust the CPI… And this "crappy" sector will benefit massively from AI.